Private Advisor Group’s Centessa Pharmaceuticals CNTA Stock Holding History

Private Advisor Group’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,000	Closed	-$238K	–	2584
2026 Q1	$238K	Buy	+6,000	New	+$153K	﹤0.01%	2356

Private Advisor Group's CNTA Position: Q2 2026 in Review

Private Advisor Group sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 6,000 shares — an estimated $238K sold.

Private Advisor Group first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $238K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Private Advisor Group reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Private Advisor Group sold 6,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $238K.
Private Advisor Group first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Private Advisor Group's Centessa Pharmaceuticals position peaked at $238K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.